Afuco™ Anti-Human AQP4 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-AQP4 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO, a study on antibody titre. Neuromyelitis optica (NMO) is an autoimmune inflammatory disorder of the central nervous system. In most NMO patients, autoantibodies to the water channel protein Aquaporin 4 (AQP4) are present at high levels and are thought to drive pathology by mediating complement-dependent destruction of astrocytes.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-051CL |
| Pricing | Inquiry |
| Host | Human |
| Target | AQP4 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at -20°C for long-term storage. Store at 4°C for up to one month. Avoid freeze/thaw cycles. |